BioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with ...

The drug's safety profile was consistent with that found in prior studies, with no new safety signals identified.

New facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations ... BDD has opened its new 122m² GMP manufacturing facility at BioCity near ...